Skip to main
ASPI

ASPI Stock Forecast & Price Target

ASPI Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

ASP Isotopes is positioned well in the market with its innovative technology, government support, and a diverse product portfolio catering to the growing demand for isotopes in various industries. With strategic partnerships and a strong team, the company has demonstrated its ability to penetrate foreign markets and establish a strong presence. The recent expansion into Hong Kong and plans for further product launches puts ASP Isotopes in a strong position for future growth and success.

Bears say

ASP Isotopes is facing several production delays and challenges due to infrastructure and technical issues, which have negatively impacted their ability to deliver commercial shipments on time. While they have made progress with their enrichment technologies and collaborations, they are still early in commercialization, leaving room for potential executional and regulatory risks. Additionally, their current financials show significant losses and high cash burn, highlighting their high-risk and unstable financial position.

ASPI has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ASP Isotopes Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ASP Isotopes Inc (ASPI) Forecast

Analysts have given ASPI a Buy based on their latest research and market trends.

According to 2 analysts, ASPI has a Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ASP Isotopes Inc (ASPI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.